(Q83334275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Michael A Bidus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Joel C Webb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jeffrey D Seidman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

G Scott Rose

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Charles R Boice

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John C Elkas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

12 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

5-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

VEGF-targeted therapy in metastatic renal cell carcinoma

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Micropapillary serous ovarian carcinoma: surgical management and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Prognostic value of histologic grading of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.048

10.1016/J.YGYNO.2006.03.048

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697451%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference